133 related articles for article (PubMed ID: 16901960)
1. Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study.
Guignard S; Gossec L; Salliot C; Ruyssen-Witrand A; Luc M; Duclos M; Dougados M
Ann Rheum Dis; 2006 Dec; 65(12):1631-4. PubMed ID: 16901960
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta-Analysis.
Bechman K; Yang Z; Adas M; Nagra D; S Uğuzlar A; Russell MD; Wilson N; Steer S; Norton S; Galloway J
Arthritis Rheumatol; 2024 May; 76(5):704-714. PubMed ID: 38116697
[TBL] [Abstract][Full Text] [Related]
3. Impact of systemic treatments on the course of HLA-B27-associated uveitis: A retrospective study of 101 patients.
Bouzid N; Jamilloux Y; Chapurlat R; Pradat P; De Parisot A; Kodjikian L; Sève P
PLoS One; 2020; 15(3):e0230560. PubMed ID: 32231384
[TBL] [Abstract][Full Text] [Related]
4. Long-term Experience with Anti-tumor Necrosis factor- α Therapy in the Treatment of Refractory, Non-infectious Intermediate, Posterior, and Panuveitis.
Corredores Dieb J; Vofo B; Amer R
Ocul Immunol Inflamm; 2022 Dec; ():1-8. PubMed ID: 36538811
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab in the therapy of uveitis in childhood.
Mansour AM
Br J Ophthalmol; 2007 Mar; 91(3):274-6. PubMed ID: 17322463
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry.
Tarsia M; Vitale A; Gaggiano C; Sota J; Maselli A; Bellantonio C; Guerriero S; Dammacco R; La Torre F; Ragab G; Hegazy MT; Fonollosa A; Paroli MP; Del Giudice E; Maggio MC; Cattalini M; Fotis L; Conti G; Mauro A; Civino A; Diomeda F; de-la-Torre A; Cifuentes-González C; Tharwat S; Hernández-Rodríguez J; Gómez-Caverzaschi V; Pelegrín L; Babu K; Gupta V; Minoia F; Ruscitti P; Costi S; Breda L; La Bella S; Conforti A; Mazzei MA; Carreño E; Amin RH; Grosso S; Frediani B; Tosi GM; Balistreri A; Cantarini L; Fabiani C
Ophthalmol Ther; 2024 Mar; 13(3):761-774. PubMed ID: 38206518
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Anti-Tumor Necrosis Factor Therapy on The Plasma Atherogenic Index in Rheumatic Diseases.
Cure O; Kizilkaya B; Ciftel S; Mercantepe F
Metab Syndr Relat Disord; 2024 May; 22(4):269-275. PubMed ID: 38252497
[No Abstract] [Full Text] [Related]
8. Anti-TNF.
Gastroenterol Hepatol (N Y); 2024 Jan; 20(1 Suppl 1):3-4. PubMed ID: 38444831
[No Abstract] [Full Text] [Related]
9. Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.
Rudwaleit M; Rødevand E; Holck P; Vanhoof J; Kron M; Kary S; Kupper H
Ann Rheum Dis; 2009 May; 68(5):696-701. PubMed ID: 18662932
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.
Lie E; Lindström U; Zverkova-Sandström T; Olsen IC; Forsblad-d'Elia H; Askling J; Kapetanovic MC; Kristensen LE; Jacobsson LTH
Ann Rheum Dis; 2017 Sep; 76(9):1515-1521. PubMed ID: 28254789
[TBL] [Abstract][Full Text] [Related]
11. Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database.
Wendling D; Joshi A; Reilly P; Jalundhwala YJ; Mittal M; Bao Y
Curr Med Res Opin; 2014 Dec; 30(12):2515-21. PubMed ID: 25252590
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review.
Zeboulon N; Dougados M; Gossec L
Ann Rheum Dis; 2008 Jul; 67(7):955-9. PubMed ID: 17962239
[TBL] [Abstract][Full Text] [Related]
13. Uveitis and spondyloarthropathies.
Sharma SM; Jackson D
Best Pract Res Clin Rheumatol; 2017 Dec; 31(6):846-862. PubMed ID: 30509444
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis.
Lee S; Park YJ; Lee JY
J Korean Med Sci; 2019 Nov; 34(42):e278. PubMed ID: 31674159
[TBL] [Abstract][Full Text] [Related]
15. Reduced Occurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis Treated with Golimumab - The GO-EASY Study.
van Bentum RE; Heslinga SC; Nurmohamed MT; Gerards AH; Griep EN; Koehorst CBJM; Kok MR; Schilder AM; Verhoef M; van der Horst-Bruinsma IE
J Rheumatol; 2019 Feb; 46(2):153-159. PubMed ID: 30385705
[TBL] [Abstract][Full Text] [Related]
16. Treatment of uveitis and ankylosing spondylitis refractory to three tumor necrosis factor alpha inhibitors drugs with golimumab.
Chaparro Sanabria JA; Bautista Molano W; Valle Oñate R
Reumatol Clin (Engl Ed); 2020; 16(1):64-65. PubMed ID: 29472171
[No Abstract] [Full Text] [Related]
17. Anti-TNFα Treatment for HLA-B27-Positive Ankylosing Spondylitis-Related Uveitis.
Kim M; Won JY; Choi SY; Ju JH; Park YH
Am J Ophthalmol; 2016 Oct; 170():32-40. PubMed ID: 27470062
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Incidence or Recurrence of Anterior Uveitis in Patients with Ankylosing Spondylitis Treated with Tumor Necrosis Factor Inhibitors.
Kwon HY; Kim YJ; Kim TH; Ahn SJ
J Clin Med; 2024 Feb; 13(3):. PubMed ID: 38337605
[No Abstract] [Full Text] [Related]
19. Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis.
Bautista-Molano W; Fernández-Ávila DG; Brance ML; Ávila Pedretti MG; Burgos-Vargas R; Corbacho I; Cosentino VL; Díaz Coto JF; Giraldo Ho E; Gomes Resende G; Gutiérrez LA; Gutiérrez M; Ibáñez Vodnizza SE; Jáuregui E; Ocampo V; Palleiro Rivero DR; Palominos PE; Pacheco Tena C; Quiceno GA; Saldarriaga-Rivera LM; Sommerfleck FA; Goecke Sariego A; Vera Barrezueta C; Vega Espinoza LE; Vega Hinojosa O; Citera G; Lozada C; Sampaio-Barros PD; Schneeberger E; Soriano ER
Nat Rev Rheumatol; 2023 Nov; 19(11):724-737. PubMed ID: 37803079
[TBL] [Abstract][Full Text] [Related]
20. Clinical characterization of patients with HLA-B27-associated uveitis and evaluation of the impact of systemic treatment on the recurrence rate: a cross-sectional study.
Pineda-Sierra JS; Cifuentes-González C; Rojas-Carabali W; Muñoz-Vargas PT; Henao-Posada A; de-la-Torre A
J Ophthalmic Inflamm Infect; 2023 Aug; 13(1):38. PubMed ID: 37646883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
